Press Releases

Tate & Lyle PLC was informed on 28 May 2003 that Barclays PLC and its subsidiaries held 28,968,069 ordinary shares in Tate & Lyle PLC on 22 May 2003 which is a notifiable interest under Section 199 of the Companies Act 1985, being 6.01 per cent. of the nominal value of the relevant share capital...

Tate & Lyle PLC announces that today, in accordance with the letter sent to the holders of 8.0% (formerly 7.5%) Unsecured Loan Stock 2003/08 and 10.75% (formerly 10.25%) Unsecured Loan Stock 2003/08 (“the Loan Stocks”) on 26 June 2003, it will redeem in full at par the Loan Stocks together with...

Lille, France (20 October 2011) – Tate & Lyle, the global ingredients and food solutions provider, is pleased to announce the start of European manufacturing of a new soluble fibre, PROMITOR™ Soluble Gluco Fibre. This comes just 18 months after the start-up of the STA-LITE® Polydextrose line in Koog...

Dr Gerry Murphy is appointed as a non-executive director and Chairman-designate of the Company.

This document has subsequently been updated and published on the 5 November 2015. Please follow this link for the updated comparative financial information.

Tate & Lyle issues the following routine trading update including comments on sweetener pricing negotiations and a statement on Western Sugar. Current Financial YearUnderlying trading in the Group for the 9 months to 31 December 2001 has continued to be in line with plan and significantly ahead of...

Please download the PDF to access the announcement.

Tate & Lyle Ventures announces today that it will invest in UK-based marine biotechnology company, Aquapharm Biodiscovery Ltd (Aquapharm). Tate & Lyle Ventures forms part of a consortium which has invested second round funding of £4.0m. Aquapharm develops natural products from the microbial resource...

A strong start to the year announced in our Q1 2016 Trading Statement supporting confidence in full year.

ACCOUNTING FOR JOINT VENTURES With effect from 1 April 2014, Tate & Lyle adopted IFRS 11 ‘Joint Arrangements’ which will change significantly the basis of accounting for its interests in joint ventures. Previously, the Group’s interests in joint ventures were accounted for by proportionate...